PremiumBespokeArtisanLuxuryCustom CBD Boxes

Yes. Hemp-derived CBD is federally legal under the 2018 Farm Bill at or below 0.3% delta-9 THC, while marijuana remains federally controlled and state-regulated.

That means CBD packaging does not carry the state cannabis symbol, seed-to-sale batch tracking or dispensary compliance stack that marijuana packaging requires. What it does carry is FDA claims exposure, because the FDA has not approved CBD as a dietary supplement or food additive. The labelling constraints are therefore about what you may say rather than what marks you must display.

Structure-function claims only. Disease claims, meaning anything stating or implying the product treats, cures, prevents or mitigates a condition, draw FDA warning letters.

The line is narrower than it looks. Supports calm is a structure-function claim, and treats anxiety is a disease claim. The FDA has issued many warning letters in this category, and they are public. Have claims language reviewed by someone who knows the distinction before anything goes to print, because a compliant redesign after a warning letter costs far more than the review.

Not federally for most hemp products, but several states now require it for hemp edibles, and it is the responsible baseline regardless.

Certification means passing the 16 CFR 1700.20 protocol: at least 80% of children aged 42–51 months fail to open it within five minutes, while at least 90% of adults aged 50–70 can open and properly reclose it. That second half matters, because a package seniors cannot open has failed the test rather than passed it.

A COA is a Certificate of Analysis, the third-party lab results showing cannabinoid content and contaminant screening for a specific batch.

In a category with no FDA pre-approval, independent verification is the main trust signal available, and a QR code linking to the batch's COA has become the expected convention rather than a differentiator. Brands that make it prominent rather than burying it consistently perform better with informed buyers, who do check it.

Full spectrum contains the plant's full cannabinoid profile including trace THC. Broad spectrum removes the THC. Isolate is pure CBD only.

Informed customers treat this as fundamental, so it belongs in the visual hierarchy rather than the small print. The practical packaging consequence is that full spectrum products contain THC, in trace amounts but present, and that should be stated plainly, because a customer consuming several servings is consuming several times that trace.

Because potency and batch numbers change with every production run, while printed cartons do not.

The standard solution is a two-layer system: a pre-printed branded carton with a designated blank area, over-printed in-house on a thermal printer with batch-specific data. Designing that zone properly, with the right size, the right position and a thermal-compatible facestock, is what separates workable CBD packaging from cartons that get written off when a batch changes.

Generally no, and it is better to state that on your site than to discover it at customs.

Even where hemp-derived CBD is federally legal domestically, most countries treat cannabinoid products under their own controlled-substance frameworks, and carrier policies vary independently of the law. Domestic shipping is not universal either, since some states restrict specific product types, so checking the destination against your product list should be part of fulfilment rather than an assumption.

500 units for most printed cartons, with 7–10 business days production.

Because the category changes formulations and compliance requirements frequently, many brands run smaller carton quantities than they otherwise would and use printed sleeves over plain cartons for versioning. That way a state rule change means reprinting a sleeve rather than writing off a pallet of cartons.